fda glp-1 compounding warning september 2025 and Novo Nordisk Warned of Telehealth Takedown. What's Next? Pharmacovigilance Assessment of Compounded GLP-1

The Study: Real-World Weight Loss Outcomes Researchers analyzed data from over 50,000 adults with obesity: 38,545 patients received a GLP-1 medication such as semaglutide or tirzepatide 12,540 patients underwent bariatric surgery, primarily gastric bypass or sleeve gastrectomy Key Findings : Surgery patients lost an average of 24% of their body weight over two years about 58 pounds

The difference between the two is that BPC-157 is typically formulated as an acetate salt, while PDA is formulated as an arginate (arginine) salt

doi: 10.1021/acsnano.7b07878 175 KandemirAkarasNimekHGrCleritrkMKklerSet al

The disappearing sperms: analysis of reports published between 1980 and 2015

similarly showed statistically significant improvement in knee symptoms and daily activity using the Tegner Lysholm Knee Scoring Scale (TLKSS) score in 126 patients with degenerative meniscus lesions and cartilage injuries after 3 months and 6 months of follow up (i.e., TLKSS: 61.9 7.4 baseline, 83.5 4.6 post- 3 months, 83.4 4.3 post- 6 months, p = 0.00065)

That means someone may take this medication at any time of day with no fasting beforehand